Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GEMCITABINE\GEMCITABINE Cause Second primary malignancy? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Second primary malignancy have been filed in association with GEMCITABINE\GEMCITABINE. This represents 0.1% of all adverse event reports for GEMCITABINE\GEMCITABINE.

14
Reports of Second primary malignancy with GEMCITABINE\GEMCITABINE
0.1%
of all GEMCITABINE\GEMCITABINE reports
5
Deaths
3
Hospitalizations

How Dangerous Is Second primary malignancy From GEMCITABINE\GEMCITABINE?

Of the 14 reports, 5 (35.7%) resulted in death, 3 (21.4%) required hospitalization, and 1 (7.1%) were considered life-threatening.

Is Second primary malignancy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GEMCITABINE\GEMCITABINE. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does GEMCITABINE\GEMCITABINE Cause?

Disease progression (951) Thrombocytopenia (939) Neutropenia (907) Anaemia (721) Nausea (603) Malignant neoplasm progression (551) Off label use (542) Death (511) Vomiting (499) Pyrexia (498)

What Other Drugs Cause Second primary malignancy?

CYCLOPHOSPHAMIDE (1,247) DOXORUBICIN (1,151) VINCRISTINE (908) IMATINIB (763) PALBOCICLIB (658) RITUXIMAB (646) RUXOLITINIB (611) ETOPOSIDE (573) PREDNISONE (517) OCTREOTIDE (496)

Which GEMCITABINE\GEMCITABINE Alternatives Have Lower Second primary malignancy Risk?

GEMCITABINE\GEMCITABINE vs GEMFIBROZIL GEMCITABINE\GEMCITABINE vs GEMTUZUMAB OZOGAMICIN GEMCITABINE\GEMCITABINE vs GEMZAR GEMCITABINE\GEMCITABINE vs GENTAMICIN GEMCITABINE\GEMCITABINE vs GEODON

Related Pages

GEMCITABINE\GEMCITABINE Full Profile All Second primary malignancy Reports All Drugs Causing Second primary malignancy GEMCITABINE\GEMCITABINE Demographics